Elixa Medicaments Private Limited

Elixa Medicaments Private Limited - pharma in Kolhapur, Maharashtra, India. FY 2026 financials and compliance.
CIN U33309PN2017PTC172931 Incorporated 10 October 2017 ROC Pune HQ Kolhapur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹24.53 Lakh
▼ 47.00% YoY
EBITDA · FY 2022
Locked
In full report
Net profit · FY 2022
Locked
In full report
Authorised capital
₹45 Lakh
Registered with MCA
Paid-up capital
₹11.73 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2022
Balance sheet date

About Elixa Medicaments Private Limited

Data last updated: 08 February 2026

Elixa Medicaments Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 10 October 2017, the company has been in operation for over 9 years.

Registered with ROC Pune under CIN U33309PN2017PTC172931.

Capital: an authorised share capital of ₹45 Lakh and a paid-up capital of ₹11.73 Lakh. It is led by directors Rashmi Rajiv Deshpande and Rajiv Vijayraj Deshpande.

Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: Csno814/2/1Awingorchidhomesfl.No.104Eward Karandemala, Kolhapur, Maharashtra, India – 416003.

As per the financials filed for FY 2022, the company reported a revenue of ₹24.53 Lakh, a decline of 47% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Elixa Medicaments Private Limited
CIN U33309PN2017PTC172931
Registration Number 172931
Incorporation Date 10 October 2017
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Csno814/2/1Awingorchidhomesfl.No.104Eward Karandemala, Kolhapur, Maharashtra, India – 416003
  • Industry
    Pharma, Drug Formulation & Development
Company report
Elixa Medicaments Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Elixa Medicaments Private Limited report

Financials, compliance, directors, charges, ownership and filings for Elixa Medicaments Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Elixa Medicaments Private Limited

Elixa Medicaments Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Elixa Medicaments Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Elixa Medicaments Private Limited

Auditor information for Elixa Medicaments Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.

Board of Directors of Elixa Medicaments Private Limited

Elixa Medicaments Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rashmi Rajiv Deshpande Director 10 Oct 2017 8 Years 9 Months Current
Rajiv Vijayraj Deshpande Director 18 Mar 2020 6 Years 4 Months Current

Financials of Elixa Medicaments Private Limited FY 2022 filings available

Elixa Medicaments Private Limited reported revenue of ₹24.53 Lakh (down 47.00% YoY) for FY 2022.

Revenue · FY 2022
₹24.53 Lakh ▼ 47.00%
Premium access

Ten-year financial statements for Elixa Medicaments Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Elixa Medicaments Private Limited

Premium access

Shareholding and ownership data for Elixa Medicaments Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Elixa Medicaments Private Limited

Elixa Medicaments Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Elixa Medicaments Private Limited

View historical data on people associated with Elixa Medicaments Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Elixa Medicaments Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Elixa Medicaments Private Limited

Premium access

GST registrations and filing compliance for Elixa Medicaments Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Elixa Medicaments Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Elixa Medicaments Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Elixa Medicaments Private Limited

Premium access

MSME payment history for Elixa Medicaments Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Elixa Medicaments Private Limited

Premium access

Corporate group structure for Elixa Medicaments Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Elixa Medicaments Private Limited

Premium access

MCA filings and documents for Elixa Medicaments Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Elixa Medicaments Private Limited

Activity
30 Sep 2022
Elixa Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Activity
31 Mar 2022
Elixa Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune.
Directors
18 Mar 2020
Rajiv Vijayraj Deshpande was appointed as a Director on 18 Mar 2020 & has been associated with this company since 6 years 4 months.
Directors
10 Oct 2017
Rashmi Rajiv Deshpande was appointed as a Director on 10 Oct 2017 & has been associated with this company since 8 years 9 months.
Activity
10 Oct 2017
Elixa Medicaments Private Limited was registered on 10 Oct 2017 with Roc Pune & aged 8 years 9 months as per MCA records.

Frequently Asked Questions about Elixa Medicaments Private Limited

Elixa Medicaments Private Limited is an active private limited company in the pharma sector based in Kolhapur, Maharashtra, India. It was incorporated on 10 October 2017 (9+ years old) and is registered under CIN U33309PN2017PTC172931.

Elixa Medicaments Private Limited reported revenue of ₹24.53 Lakh for FY 2022 (down 47.00% YoY).

The current directors of Elixa Medicaments Private Limited are:

The primary industry of Elixa Medicaments Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Elixa Medicaments Private Limited can be reached at the registered office: Csno81421Awingorchidhomesfl.No.104Eward Karandemala, Kolhapur, Maharashtra, India – 416003.

The authorised capital is ₹45 Lakh, and the paid-up capital is ₹11.73 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available